Inventors
& entrepreneurs.

We create human-relevant solutions for drug discovery. 
Founded at the University of Geneva, FluoSphera is shaping
in vitro human biology.

2021

Founded

2

Offices

18'000+

Citations of
co-founders publications

5+

Partner organisations

We built FluoSphera to bring
human in vitro biology closer to real world
drug decisions.

Gregory Segala, Ph.D.
CSO & CO-founder

The people behind 
the science.

Leadership

Dimitri Pappaioannou

VP Corporate & Business Development

+

Gregory Segala

CSO & Co-Founder

+

Clélia Bourgoint

CEO, Chair & Co-Founder

+

Nathalie Rowell

Board member

+

Panteli Theocharous

Board member

+

Leadership

Guido Koch

Scientific Advisor

+

Gerardo Turcatti

Scientific Advisor

+

Aurélien Roux

Scientific Advisor & Co-Founder

+

Dimitri Moreau

Scientific Advisor

+

partnership models

Partnerships driving better biological insight.

O1

02

Epithelix company logo

03

04

05

Sciomix company logo

06

07

Built through years of translational research.

01020304

Invented the multiplexing technology.

Illustration of a Fluosphera team scientist

Built on core encapsulation technology developed in Aurélien Roux’s lab at the University of Geneva.

01020304

Founded FluoSphera SA.

Exterior of the Stellar office building housing Fluosphera's headquarters

Established in Geneva, Switzerland, with FONGIT incubation support.

01020304

Revvity partnership announced.

Illustration of microscopic analysis by the Fluosphera team


Combined FluoSphera’s platform with high-content screening capabilities for PROTAC selectivity assessment.

01020304

Pleiad launch.

Illustration of team working on a product


Making 3D cell culture accessible to any life sciences laboratory.

partnership models

Predictive biology

Bring the platform in house with flexible licensing options for your organization.

email
Name
company
message
Partnership
Your submission has been received
Oops! Something went wrong while submitting the form.

starts today